"Abagovomab, the Immunotherapy for Ovarian Cancer: Can We Increase Survival?"

First Part -Second Part - Third Part

JONATHAN S. BEREK
Professor and Chair, Obstetrics and Gynaecology
Stanford Women’s Cancer Center, Stanford University School of Medicine,
Stanford, California – U.S.A.

First Part

Second Part